Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Killer Cells, Natural | 13 | 2023 | 2211 | 1.720 |
Why?
|
Immunotherapy, Adoptive | 4 | 2020 | 1512 | 0.730 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2019 | 23 | 0.670 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2019 | 85 | 0.660 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2021 | 210 | 0.650 |
Why?
|
Interleukin-15 | 4 | 2023 | 186 | 0.480 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1907 | 0.380 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1816 | 0.370 |
Why?
|
Myeloid Progenitor Cells | 1 | 2010 | 112 | 0.350 |
Why?
|
Receptors, Immunologic | 2 | 2006 | 1418 | 0.300 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2019 | 3626 | 0.260 |
Why?
|
Cell Differentiation | 5 | 2019 | 11677 | 0.220 |
Why?
|
Receptors, KIR3DL1 | 2 | 2019 | 27 | 0.220 |
Why?
|
Flow Cytometry | 4 | 2022 | 5902 | 0.200 |
Why?
|
Adrenoleukodystrophy | 1 | 2024 | 144 | 0.200 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2023 | 1375 | 0.200 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5863 | 0.200 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2021 | 93 | 0.190 |
Why?
|
Lentivirus | 1 | 2024 | 518 | 0.190 |
Why?
|
Immunophenotyping | 3 | 2022 | 1864 | 0.180 |
Why?
|
Toxoplasmosis | 1 | 2021 | 94 | 0.180 |
Why?
|
Ki-67 Antigen | 1 | 2002 | 630 | 0.170 |
Why?
|
Leukemia | 1 | 2008 | 1519 | 0.170 |
Why?
|
Toxoplasma | 1 | 2021 | 159 | 0.170 |
Why?
|
Immunoblastic Lymphadenopathy | 2 | 2017 | 40 | 0.170 |
Why?
|
Receptors, KIR2DL2 | 1 | 2019 | 6 | 0.170 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2021 | 4415 | 0.160 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 1560 | 0.160 |
Why?
|
HLA-C Antigens | 1 | 2019 | 146 | 0.160 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2020 | 1437 | 0.150 |
Why?
|
HLA-B Antigens | 1 | 2019 | 330 | 0.140 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 271 | 0.140 |
Why?
|
HLA Antigens | 3 | 2009 | 1334 | 0.140 |
Why?
|
Lymphoid Tissue | 1 | 2018 | 445 | 0.130 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2016 | 40 | 0.130 |
Why?
|
Antigens, CD19 | 2 | 2020 | 446 | 0.130 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2017 | 125 | 0.120 |
Why?
|
Genetic Vectors | 1 | 2024 | 3403 | 0.120 |
Why?
|
Stromal Cells | 3 | 2010 | 1337 | 0.120 |
Why?
|
Immunotherapy | 2 | 2023 | 4754 | 0.120 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2016 | 235 | 0.120 |
Why?
|
Lymphoma, Follicular | 1 | 2019 | 460 | 0.120 |
Why?
|
Diphtheria Toxin | 1 | 2015 | 253 | 0.110 |
Why?
|
Myelodysplastic Syndromes | 2 | 2024 | 1399 | 0.110 |
Why?
|
Hematopoietic Stem Cells | 1 | 2006 | 3409 | 0.110 |
Why?
|
Bone Marrow | 3 | 2021 | 2935 | 0.110 |
Why?
|
Lymphoma, T-Cell | 1 | 2016 | 308 | 0.110 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2414 | 0.100 |
Why?
|
Coculture Techniques | 3 | 2020 | 1344 | 0.100 |
Why?
|
K562 Cells | 2 | 2010 | 644 | 0.100 |
Why?
|
Herpesvirus 4, Human | 1 | 2016 | 1082 | 0.090 |
Why?
|
Receptors, KIR | 2 | 2019 | 114 | 0.090 |
Why?
|
Antigens, CD | 3 | 2019 | 4035 | 0.090 |
Why?
|
Colony-Forming Units Assay | 1 | 2010 | 351 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2605 | 0.090 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 617 | 0.090 |
Why?
|
Lymph Nodes | 1 | 2022 | 3474 | 0.090 |
Why?
|
Immunohistochemistry | 3 | 2022 | 11095 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1673 | 0.080 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2008 | 14 | 0.080 |
Why?
|
Leukemia, Experimental | 1 | 2009 | 225 | 0.080 |
Why?
|
Humans | 28 | 2024 | 768171 | 0.080 |
Why?
|
Graft vs Host Reaction | 1 | 2008 | 99 | 0.080 |
Why?
|
Antigens, CD34 | 1 | 2010 | 657 | 0.080 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2008 | 317 | 0.080 |
Why?
|
Central Nervous System Neoplasms | 1 | 2016 | 928 | 0.080 |
Why?
|
Histocompatibility Testing | 1 | 2009 | 716 | 0.070 |
Why?
|
Self Tolerance | 1 | 2008 | 122 | 0.070 |
Why?
|
Antibodies | 1 | 2015 | 2421 | 0.070 |
Why?
|
Cell Count | 1 | 2010 | 1832 | 0.070 |
Why?
|
Organ Transplantation | 1 | 2016 | 1176 | 0.070 |
Why?
|
B-Lymphocytes | 2 | 2016 | 4793 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2956 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4916 | 0.060 |
Why?
|
Lymphocyte Subsets | 1 | 2007 | 313 | 0.060 |
Why?
|
Adoptive Transfer | 1 | 2008 | 825 | 0.060 |
Why?
|
Vaccination | 1 | 2018 | 3437 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4648 | 0.060 |
Why?
|
Major Histocompatibility Complex | 1 | 2008 | 877 | 0.060 |
Why?
|
Natural Killer T-Cells | 1 | 2008 | 318 | 0.060 |
Why?
|
Fetal Blood | 2 | 2009 | 1361 | 0.060 |
Why?
|
Cyclosporine | 1 | 2007 | 777 | 0.060 |
Why?
|
Receptors, IgG | 1 | 2007 | 564 | 0.060 |
Why?
|
Young Adult | 6 | 2022 | 60066 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1642 | 0.050 |
Why?
|
Antigens, Differentiation | 1 | 2006 | 921 | 0.050 |
Why?
|
Transplantation, Homologous | 2 | 2009 | 4834 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2009 | 1361 | 0.050 |
Why?
|
Adolescent | 6 | 2024 | 89169 | 0.050 |
Why?
|
Receptors, KIR2DL1 | 1 | 2002 | 13 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5717 | 0.050 |
Why?
|
Hydrocortisone | 1 | 2010 | 1841 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13668 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39354 | 0.050 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2002 | 510 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1250 | 0.050 |
Why?
|
Up-Regulation | 1 | 2010 | 4149 | 0.050 |
Why?
|
Niacinamide | 1 | 2023 | 418 | 0.050 |
Why?
|
Cells, Cultured | 3 | 2010 | 19025 | 0.040 |
Why?
|
Aged | 8 | 2021 | 171502 | 0.040 |
Why?
|
Middle Aged | 9 | 2022 | 223487 | 0.040 |
Why?
|
Graft vs Host Disease | 2 | 2009 | 3049 | 0.040 |
Why?
|
Child | 4 | 2024 | 80917 | 0.040 |
Why?
|
Child, Preschool | 2 | 2021 | 42669 | 0.040 |
Why?
|
Adult | 9 | 2022 | 223646 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2022 | 81760 | 0.040 |
Why?
|
Yellow Fever Vaccine | 1 | 2018 | 38 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4249 | 0.040 |
Why?
|
Clonal Anergy | 1 | 2018 | 169 | 0.040 |
Why?
|
Male | 10 | 2024 | 364731 | 0.040 |
Why?
|
HIV Seronegativity | 1 | 2018 | 210 | 0.040 |
Why?
|
Female | 10 | 2024 | 397187 | 0.040 |
Why?
|
Biopsy | 2 | 2021 | 6792 | 0.030 |
Why?
|
Chemokine CXCL13 | 1 | 2017 | 62 | 0.030 |
Why?
|
HIV Infections | 2 | 2020 | 17569 | 0.030 |
Why?
|
Eye Proteins | 1 | 2020 | 628 | 0.030 |
Why?
|
Minnesota | 1 | 2016 | 339 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2002 | 1895 | 0.030 |
Why?
|
Ligands | 1 | 2002 | 3284 | 0.030 |
Why?
|
Splenomegaly | 1 | 2016 | 192 | 0.030 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2017 | 168 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2020 | 1133 | 0.030 |
Why?
|
Immunotoxins | 1 | 2015 | 175 | 0.030 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2015 | 99 | 0.030 |
Why?
|
Neuropeptides | 1 | 2020 | 951 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4206 | 0.030 |
Why?
|
Gene Silencing | 1 | 2020 | 1505 | 0.030 |
Why?
|
Uganda | 1 | 2018 | 1361 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2018 | 5505 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 733 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1904 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2015 | 899 | 0.030 |
Why?
|
Cell Line | 1 | 2006 | 15602 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2016 | 10266 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2020 | 2004 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2020 | 2152 | 0.020 |
Why?
|
Mice | 4 | 2023 | 82049 | 0.020 |
Why?
|
Microvessels | 1 | 2016 | 585 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2020 | 2568 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 30237 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 998 | 0.020 |
Why?
|
Fibrosis | 1 | 2018 | 2081 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11930 | 0.020 |
Why?
|
Animals | 5 | 2023 | 169285 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2645 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2892 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2018 | 2323 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3623 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3670 | 0.020 |
Why?
|
Cytokines | 2 | 2018 | 7452 | 0.020 |
Why?
|
RNA, Viral | 1 | 2016 | 2874 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59626 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 2009 | 0.020 |
Why?
|
Cell Degranulation | 1 | 2008 | 277 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4120 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8542 | 0.020 |
Why?
|
DNA | 1 | 2021 | 7213 | 0.020 |
Why?
|
Graft vs Leukemia Effect | 1 | 2007 | 121 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8509 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2018 | 3214 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2007 | 199 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2007 | 432 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2007 | 472 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5804 | 0.020 |
Why?
|
NFATC Transcription Factors | 1 | 2007 | 393 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2009 | 1837 | 0.010 |
Why?
|
Genotype | 1 | 2019 | 13045 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11244 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12543 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5341 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9540 | 0.010 |
Why?
|
Mice, SCID | 1 | 2009 | 2627 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9497 | 0.010 |
Why?
|
Cell Separation | 1 | 2008 | 1728 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10763 | 0.010 |
Why?
|
Calcium Signaling | 1 | 2007 | 737 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22290 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15453 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2008 | 3161 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2007 | 2885 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16726 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18065 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4363 | 0.010 |
Why?
|
Apoptosis | 1 | 2008 | 9527 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2009 | 4282 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 65379 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54924 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 17142 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2007 | 10478 | 0.010 |
Why?
|
United States | 1 | 2017 | 73039 | 0.000 |
Why?
|
Time Factors | 1 | 2007 | 40220 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2009 | 13586 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 74944 | 0.000 |
Why?
|